The Systemic Effects of Exercise on the Systemic Effects of Alzheimer’s Disease
Open Access
- 23 May 2022
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 11 (5) , 1028
Abstract
Alzheimer’s disease (AD) is a progressive degenerative disorder and a leading cause of dementia in the elderly. The etiology of AD is multifactorial, including an increased oxidative state, deposition of amyloid plaques, and neurofibrillary tangles of the tau protein. The formation of amyloid plaques is considered one of the first signs of the illness, but only in the central nervous system (CNS). Interestingly, results indicate that AD is not just localized in the brain but is also found in organs distant from the brain, such as the cardiovascular system, gut microbiome, liver, testes, and kidney. These observations make AD a complex systemic disorder. Still, no effective medications have been found, but regular physical activity has been considered to have a positive impact on this challenging disease. While several articles have been published on the benefits of physical activity on AD development in the CNS, its peripheral effects have not been discussed in detail. The provocative question arising is the following: is it possible that the beneficial effects of regular exercise on AD are due to the systemic impact of training, rather than just the effects of exercise on the brain? If so, does this mean that the level of fitness of these peripheral organs can directly or indirectly influence the incidence or progress of AD? Therefore, the present paper aims to summarize the systemic effects of both regular exercise and AD and point out how common exercise-induced adaptation via peripheral organs can decrease the incidence of AD or attenuate the progress of AD.Keywords
Funding Information
- Innovációs és Technológiai Minisztérium (126823, TKP2020-NKA-17, TKP2021-EGA-37)
- University of Physical Education (126823, TKP2020-NKA-17, TKP2021-EGA-37)
This publication has 147 references indexed in Scilit:
- Alzheimer's disease and the microbiomeFrontiers in Cellular Neuroscience, 2013
- Inflammation in Polycystic Ovary Syndrome: Underpinning of insulin resistance and ovarian dysfunctionSteroids, 2012
- The projected effect of risk factor reduction on Alzheimer's disease prevalenceThe Lancet Neurology, 2011
- Endothelial nitric oxide synthase transgenic models of endothelial dysfunctionPflügers Archiv - European Journal of Physiology, 2010
- Oligemic Hypoperfusion Differentially Affects Tau and Amyloid-βThe American Journal of Pathology, 2010
- Protein Aggregates and Novel Presenilin Gene Variants in Idiopathic Dilated CardiomyopathyCirculation, 2010
- Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell MonolayersThe Journal of Nutrition, 2009
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Transcriptional regulation by the phosphorylation-dependent factor CREBNature Reviews Molecular Cell Biology, 2001
- Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNACell, 1996